REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 82 filers reported holding REPROS THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $2,000 | +100.0% | 900 | +1025.0% | 0.00% | – |
Q3 2015 | $1,000 | 0.0% | 80 | +21.2% | 0.00% | – |
Q1 2015 | $1,000 | -99.7% | 66 | -99.8% | 0.00% | – |
Q3 2014 | $297,000 | -79.8% | 30,008 | -62.6% | 0.00% | -100.0% |
Q4 2013 | $1,468,000 | -0.4% | 80,200 | +45.8% | 0.00% | +100.0% |
Q3 2013 | $1,474,000 | – | 55,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 1,001,000 | $970,000 | 0.21% |
Allegis Investment Advisors, LLC | 341,669 | $331,000 | 0.19% |
GENERAL AMERICAN INVESTORS CO INC | 396,123 | $384,000 | 0.04% |
Alambic Investment Management, L.P. | 114,591 | $111,000 | 0.04% |
Gruss Capital Management LP | 600,000 | $582,000 | 0.02% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 102,086 | $99,000 | 0.01% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 323,429 | $314,000 | 0.01% |
GSA CAPITAL PARTNERS LLP | 27,931 | $27,000 | 0.00% |
BENJAMIN F. EDWARDS & COMPANY, INC. | 2,700 | $3,000 | 0.00% |
Airain ltd | 13,690 | $13,000 | 0.00% |